Boston Partners’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-61,219
| Closed | -$2.19M | – | 652 |
|
|
2021
Q1 | $2.19M | Sell |
61,219
-5,493,953
| -99% | -$196M | ﹤0.01% | 473 |
|
|
2020
Q4 | $204M | Sell |
5,555,172
-236,855
| -4% | -$8.72M | 0.32% | 99 |
|
|
2020
Q3 | $218M | Sell |
5,792,027
-278,496
| -5% | -$10.5M | 0.4% | 84 |
|
|
2020
Q2 | $248M | Sell |
6,070,523
-4,187,319
| -41% | -$171M | 0.45% | 73 |
|
|
2020
Q1 | $389M | Buy |
10,257,842
+2,073,527
| +25% | +$78.6M | 0.77% | 35 |
|
|
2019
Q4 | $385M | Buy |
8,184,315
+6,761,520
| +475% | +$318M | 0.51% | 65 |
|
|
2019
Q3 | $60.8M | Sell |
1,422,795
-76,215
| -5% | -$3.25M | 0.08% | 228 |
|
|
2019
Q2 | $60M | Sell |
1,499,010
-82,333
| -5% | -$3.3M | 0.08% | 225 |
|
|
2019
Q1 | $66.1M | Sell |
1,581,343
-125,908
| -7% | -$5.26M | 0.09% | 218 |
|
|
2018
Q4 | $65.2M | Buy |
+1,707,251
| New | +$65.2M | 0.09% | 214 |
|